- Home
- HALO vs CLS Comparison
HALO vs CLS Comparison
Compare HALO & CLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- CLS
- Stock Information
- Founded
- HALO 1998
- CLS 1994
- Country
- HALO United States
- CLS Canada
- Employees
- HALO N/A
- CLS N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- CLS Electrical Products
- Sector
- HALO Health Care
- CLS Technology
- Exchange
- HALO Nasdaq
- CLS Nasdaq
- Market Cap
- HALO 6.4B
- CLS 6.9B
- IPO Year
- HALO N/A
- CLS 1998
- Fundamental
- Price
- HALO $49.00
- CLS $89.15
- Analyst Decision
- HALO Buy
- CLS Strong Buy
- Analyst Count
- HALO 9
- CLS 9
- Target Price
- HALO $61.11
- CLS $72.44
- AVG Volume (30 Days)
- HALO 2.3M
- CLS 2.6M
- Earning Date
- HALO 10-31-2024
- CLS 10-23-2024
- Dividend Yield
- HALO N/A
- CLS N/A
- EPS Growth
- HALO 61.71
- CLS 88.40
- EPS
- HALO 3.02
- CLS 3.16
- Revenue
- HALO $947,355,000.00
- CLS $9,240,800,000.00
- Revenue This Year
- HALO $23.36
- CLS $21.97
- Revenue Next Year
- HALO $15.15
- CLS $8.98
- P/E Ratio
- HALO $16.21
- CLS $27.47
- Revenue Growth
- HALO 21.35
- CLS 17.52
- 52 Week Low
- HALO $33.15
- CLS $25.84
- 52 Week High
- HALO $65.53
- CLS $93.15
- Technical
- Relative Strength Index (RSI)
- HALO 43.09
- CLS 73.54
- Support Level
- HALO $42.01
- CLS $83.36
- Resistance Level
- HALO $46.20
- CLS $93.15
- Average True Range (ATR)
- HALO 2.76
- CLS 3.75
- MACD
- HALO -1.08
- CLS 0.20
- Stochastic Oscillator
- HALO 34.74
- CLS 79.64
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About CLS Celestica Inc.
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.